Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 103

1.

Japanese encephalitis virus vaccine candidates generated by chimerization with dengue virus type 4.

Gromowski GD, Firestone CY, Hanson CT, Whitehead SS.

Vaccine. 2014 May 23;32(25):3010-8. doi: 10.1016/j.vaccine.2014.03.062. Epub 2014 Mar 31.

PMID:
24699473
[PubMed - in process]
2.

Substitution of the structural genes of dengue virus type 4 with those of type 2 results in chimeric vaccine candidates which are attenuated for mosquitoes, mice, and rhesus monkeys.

Whitehead SS, Hanley KA, Blaney JE Jr, Gilmore LE, Elkins WR, Murphy BR.

Vaccine. 2003 Oct 1;21(27-30):4307-16.

PMID:
14505913
[PubMed - indexed for MEDLINE]
3.

A chimeric dengue virus vaccine using Japanese encephalitis virus vaccine strain SA14-14-2 as backbone is immunogenic and protective against either parental virus in mice and nonhuman primates.

Li XF, Deng YQ, Yang HQ, Zhao H, Jiang T, Yu XD, Li SH, Ye Q, Zhu SY, Wang HJ, Zhang Y, Ma J, Yu YX, Liu ZY, Li YH, Qin ED, Shi PY, Qin CF.

J Virol. 2013 Dec;87(24):13694-705. doi: 10.1128/JVI.00931-13. Epub 2013 Oct 9.

PMID:
24109223
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Recombinant, chimaeric live, attenuated vaccine (ChimeriVax) incorporating the envelope genes of Japanese encephalitis (SA14-14-2) virus and the capsid and nonstructural genes of yellow fever (17D) virus is safe, immunogenic and protective in non-human primates.

Monath TP, Soike K, Levenbook I, Zhang ZX, Arroyo J, Delagrave S, Myers G, Barrett AD, Shope RE, Ratterree M, Chambers TJ, Guirakhoo F.

Vaccine. 1999 Apr 9;17(15-16):1869-82.

PMID:
10217584
[PubMed - indexed for MEDLINE]
5.

Comparison of live and inactivated tick-borne encephalitis virus vaccines for safety, immunogenicity and efficacy in rhesus monkeys.

Rumyantsev AA, Chanock RM, Murphy BR, Pletnev AG.

Vaccine. 2006 Jan 12;24(2):133-43. Epub 2005 Aug 9.

PMID:
16115704
[PubMed - indexed for MEDLINE]
6.

Vaccine candidates for dengue virus type 1 (DEN1) generated by replacement of the structural genes of rDEN4 and rDEN4Delta30 with those of DEN1.

Blaney JE Jr, Sathe NS, Hanson CT, Firestone CY, Murphy BR, Whitehead SS.

Virol J. 2007 Feb 28;4:23.

PMID:
17328799
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Molecular basis for attenuation of neurovirulence of a yellow fever Virus/Japanese encephalitis virus chimera vaccine (ChimeriVax-JE).

Arroyo J, Guirakhoo F, Fenner S, Zhang ZX, Monath TP, Chambers TJ.

J Virol. 2001 Jan;75(2):934-42.

PMID:
11134306
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Construction and preliminary investigation of a novel dengue serotype 4 chimeric virus using Japanese encephalitis vaccine strain SA14-14-2 as the backbone.

Li Z, Yang H, Yang J, Lin H, Wang W, Liu L, Zhao Y, Liu L, Zeng X, Yu Y, Li Y.

Virus Res. 2014 Oct 13;191:10-20. doi: 10.1016/j.virusres.2014.07.017. Epub 2014 Aug 1.

PMID:
25091563
[PubMed - in process]
10.

Chimeric yellow fever virus 17D-Japanese encephalitis virus vaccine: dose-response effectiveness and extended safety testing in rhesus monkeys.

Monath TP, Levenbook I, Soike K, Zhang ZX, Ratterree M, Draper K, Barrett AD, Nichols R, Weltzin R, Arroyo J, Guirakhoo F.

J Virol. 2000 Feb;74(4):1742-51.

PMID:
10644345
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Genetically modified, live attenuated dengue virus type 3 vaccine candidates.

Blaney JE Jr, Hanson CT, Firestone CY, Hanley KA, Murphy BR, Whitehead SS.

Am J Trop Med Hyg. 2004 Dec;71(6):811-21.

PMID:
15642976
[PubMed - indexed for MEDLINE]
Free Article
12.

Protection of SA14-14-2 live attenuated Japanese encephalitis vaccine against the wild-type JE viruses.

Jia L, Wang Z, Yu Y.

Chin Med J (Engl). 2003 Jun;116(6):941-3.

PMID:
12877812
[PubMed - indexed for MEDLINE]
Free Article
13.
14.

Preclinical and clinical development of YFV 17D-based chimeric vaccines against dengue, West Nile and Japanese encephalitis viruses.

Guy B, Guirakhoo F, Barban V, Higgs S, Monath TP, Lang J.

Vaccine. 2010 Jan 8;28(3):632-49. doi: 10.1016/j.vaccine.2009.09.098. Epub 2009 Oct 4. Review.

PMID:
19808029
[PubMed - indexed for MEDLINE]
15.

Dengue 2 PDK-53 virus as a chimeric carrier for tetravalent dengue vaccine development.

Huang CY, Butrapet S, Tsuchiya KR, Bhamarapravati N, Gubler DJ, Kinney RM.

J Virol. 2003 Nov;77(21):11436-47.

PMID:
14557629
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Evaluation of the Langat/dengue 4 chimeric virus as a live attenuated tick-borne encephalitis vaccine for safety and immunogenicity in healthy adult volunteers.

Wright PF, Ankrah S, Henderson SE, Durbin AP, Speicher J, Whitehead SS, Murphy BR, Pletnev AG.

Vaccine. 2008 Feb 13;26(7):882-90. doi: 10.1016/j.vaccine.2007.12.015. Epub 2008 Jan 4.

PMID:
18207289
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Generation and preclinical evaluation of a DENV-1/2 prM+E chimeric live attenuated vaccine candidate with enhanced prM cleavage.

Keelapang P, Nitatpattana N, Suphatrakul A, Punyahathaikul S, Sriburi R, Pulmanausahakul R, Pichyangkul S, Malasit P, Yoksan S, Sittisombut N.

Vaccine. 2013 Oct 17;31(44):5134-40. doi: 10.1016/j.vaccine.2013.08.027. Epub 2013 Aug 22.

PMID:
23973247
[PubMed - indexed for MEDLINE]
18.

Infectivity of West Nile/dengue chimeric viruses for West Nile and dengue mosquito vectors.

Hanley KA, Goddard LB, Gilmore LE, Scott TW, Speicher J, Murphy BR, Pletnev AG.

Vector Borne Zoonotic Dis. 2005 Spring;5(1):1-10.

PMID:
15815144
[PubMed - indexed for MEDLINE]
19.

Dengue type 4 live-attenuated vaccine viruses passaged in vero cells affect genetic stability and dengue-induced hemorrhaging in mice.

Lee HC, Yen YT, Chen WY, Wu-Hsieh BA, Wu SC.

PLoS One. 2011;6(10):e25800. doi: 10.1371/journal.pone.0025800. Epub 2011 Oct 28.

PMID:
22053180
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Mutations which enhance the replication of dengue virus type 4 and an antigenic chimeric dengue virus type 2/4 vaccine candidate in Vero cells.

Blaney JE Jr, Manipon GG, Firestone CY, Johnson DH, Hanson CT, Murphy BR, Whitehead SS.

Vaccine. 2003 Oct 1;21(27-30):4317-27.

PMID:
14505914
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk